Mechanism of inhibitory effect of 3-hydroxykynurenine on erythropoiesis in patients with renal insufficiency

Adv Exp Med Biol. 2003:527:375-80. doi: 10.1007/978-1-4615-0135-0_43.

Abstract

Increase of 3-hydroxykynurenine (3-HKYN) concentration was observed in plasma patients with chronic renal insufficiency (CRI). These changes positively correlated with the concentration of creatinine, but negatively correlated with haematological parameters: haematocrit, haemoglobin and red blood cells count. The changes were accompanied by a slight decrease of the concentration of erythropoietin (EPO) in plasma of patients with CRI. The "in vitro" study in the conditions of hypoxia showed that 3-HKYN inhibited the release of EPO from HepG2 cells to the culture base. In conclusion, the erythropoiesis in CRI could be attributed to the influence of 3-HKYN on EPO synthesis. Thus, we propose that 3-HKYN can be an uraemic of toxin partially responsible for anaemia patients with CRI.

MeSH terms

  • Adult
  • Aged
  • Anemia / blood
  • Anemia / etiology
  • Case-Control Studies
  • Cell Line
  • Erythropoiesis / drug effects*
  • Erythropoiesis / physiology
  • Erythropoietin / blood
  • Female
  • Humans
  • In Vitro Techniques
  • Kidney Failure, Chronic / blood*
  • Kidney Failure, Chronic / complications
  • Kynurenine / analogs & derivatives*
  • Kynurenine / blood
  • Kynurenine / pharmacology*
  • Male
  • Middle Aged

Substances

  • Erythropoietin
  • 3-hydroxykynurenine
  • Kynurenine